A Study of Cadonilimab（AK104） Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Phase 2
Recruiting
- Conditions
- Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
- Interventions
- Drug: AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 28
- Registration Number
- NCT06035224
- Locations
- 🇨🇳
Shanghai Renji Hospital, Shanghai, Shanghai, China
Exploratory Research of PCSK9 Inhibitor on Patency of aAVF After PTA With PCB
Not Applicable
Recruiting
- Conditions
- Hemodialysis Access Failure
- Interventions
- Biological: pcsk9 inhibitor
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06034691
- Locations
- 🇨🇳
Yuanyuan Xie, Shanghai, Pudong, China
Sodium Valproate in Patients With Acute Ischemic Stroke
Phase 2
Recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Drug: Normal saline
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06020898
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Hydroxychloroquine May be Beneficial for Preeclampsia
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 462
- Registration Number
- NCT06020378
- Locations
- 🇨🇳
Shanghai Jiao Tong University School of Medicine，Renji Hospital, Shanghai, Shanghai, China
Ciprofol vs Propofol for Reducing Hypoxia Incidence in ERCP
Not Applicable
Not yet recruiting
- Conditions
- Biliary Tract DiseasesAnesthesia; Adverse Effect
- Interventions
- First Posted Date
- 2023-08-29
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 136
- Registration Number
- NCT06015074
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiao Tong University School of Medicine,, Shanghai, Shanghai, China
Mental Stress and Bowel Preparation Quality
Recruiting
- Conditions
- ColonoscopyIntestinal Disease
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06007313
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis
Not yet recruiting
- Conditions
- the Dynamic Evolution of Endometrial CarcinogenesisMultiomics Analysis
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06007300
The Effects of Remimazolam on the Incidence of Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients
Not Applicable
Not yet recruiting
- Conditions
- HypoxiaHysteroscopyOverweight or Obesity
- Interventions
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2023-08-28
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT06004843
- Locations
- 🇨🇳
Renji Hospital, Shanghai, Pudong New Area, China
[68Ga] NOTA-SGC8 in the Staging of Bladder Cancer
Not Applicable
Recruiting
- Conditions
- Bladder Cancer
- Interventions
- Radiation: [68Ga]-NOTA-SGC8
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT06005116
- Locations
- 🇨🇳
Renji Hospital, Shanghai, Shanghai, China
Feasibility Study of Peripheral Venous Cannulation Pain in Predicting Acute Pain After Total Knee Arthroplasty
Not yet recruiting
- Conditions
- Venous Cannulation PainMovement-evoked PainTotal Knee ArthroplastyAcute Pain
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT06002724
© Copyright 2025. All Rights Reserved by MedPath